Santiago’s team showed that GZMA can be involved in tumor development and is a potential prognostic target for various cancers; this may be due to the ability of extracellular GZMA to promote the production of NF-κB-dependent IL6 in macrophages (25). The gene discussed is NFKB1; the disease is cancer.